Tandem Diabetes Care Inc (TNDM) — Cash Flow-to-Debt Ratio
Tandem Diabetes Care Inc (TNDM) has a Cash Flow-to-Debt Ratio of 0.01x as of March 2026, meaning its operating cash flow of $11.05 Million could theoretically repay 0% of its total liabilities ($1.02 Billion) in one year. Explore long-term investment intensity of Tandem Diabetes Care Inc to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tandem Diabetes Care Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Tandem Diabetes Care Inc across 15 annual periods. Also explore TNDM total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Tandem Diabetes Care Inc (2011–2025)
Year-by-year debt coverage analysis for Tandem Diabetes Care Inc. For market capitalisation and broader financial context, see Tandem Diabetes Care Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | $-9.72 Million | $725.94 Million | ▼ -138.9% |
| 2024 | 0.03x | $24.23 Million | $704.56 Million | ▲ +169.1% |
| 2023 | -0.05x | $-31.81 Million | $639.03 Million | ▼ -160.5% |
| 2022 | 0.08x | $50.46 Million | $612.84 Million | ▼ -65.1% |
| 2021 | 0.24x | $111.36 Million | $472.02 Million | ▲ +234.8% |
| 2020 | 0.07x | $24.67 Million | $350.11 Million | ▼ -78.0% |
| 2019 | 0.32x | $41.91 Million | $131.13 Million | ▲ +388.2% |
| 2018 | -0.11x | $-8.32 Million | $75.02 Million | ▲ +79.1% |
| 2017 | -0.53x | $-66.14 Million | $124.49 Million | ▼ -2.8% |
| 2016 | -0.52x | $-61.17 Million | $118.32 Million | ▲ +45.8% |
| 2015 | -0.95x | $-58.76 Million | $61.65 Million | ▲ +19.4% |
| 2014 | -1.18x | $-61.38 Million | $51.89 Million | ▼ -15.6% |
| 2013 | -1.02x | $-47.76 Million | $46.68 Million | ▼ -345.9% |
| 2012 | -0.23x | $-33.47 Million | $145.87 Million | ▲ +9.2% |
| 2011 | -0.25x | $-21.55 Million | $85.27 Million | — |